Image pharmaphorum Editor News Prostate drug approved for use in non-metastatic cases The US Food and Drug Administration has approved the drug Xtandi (enzalutamide) to treat men with advanced non-metastatic prostate cancer. News Type 2 diabetes research: fewer side effects from modified m... Scientists have made progress in the quest to find medication for Type 2 diabetes that causes fewer side effects than current treatments. News China strives to lower cost of cancer drugs as disease rates... China is pushing domestic and overseas markets to lower the cost of cancer drugs to make them more accessible. News Novartis to cease antibiotic R&D despite superbug threat Yet another big pharma quits antibiotics research Load more results
News Prostate drug approved for use in non-metastatic cases The US Food and Drug Administration has approved the drug Xtandi (enzalutamide) to treat men with advanced non-metastatic prostate cancer.
News Type 2 diabetes research: fewer side effects from modified m... Scientists have made progress in the quest to find medication for Type 2 diabetes that causes fewer side effects than current treatments.
News China strives to lower cost of cancer drugs as disease rates... China is pushing domestic and overseas markets to lower the cost of cancer drugs to make them more accessible.
News Novartis to cease antibiotic R&D despite superbug threat Yet another big pharma quits antibiotics research
News UK spurs prescribing of obesity jab Mounjaro with GP bonus Doctors in the UK will be given thousands of pounds in bonus payments from April for prescribing Eli Lilly's weight-loss drug Mounjaro.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
